Global Cardiac Pacemaker Market will exceed USD 12.00 billion by 2021: Zion Market Research
/
Date15 Dec 2016
Sarasota, FL, Dec. 15, 2016 (GLOBE NEWSWIRE) — Zion Research has published a new report titled “Cardiac Pacemaker Market by Product (Implantable Cardiac Pacemaker and... Read More →
TiGenix lève $ 35,65 millions suite à son IPO sur le NASDAQ
/
Date15 Dec 2016
COMMUNIQUE DE PRESSEINFORMATION REGLEMENTEE Louvain (BELGIQUE) – 15 décembre 2016, 3:00h CET – TiGenix NV (Euronext Bruxelles: TIG; “TiGenix”), une société biopharmaceutique de pointe centrée sur... Read More →
TiGenix raises $35.65 million gross proceeds with NASDAQ IPO
/
Date15 Dec 2016
PRESS RELEASEREGULATED INFORMATION Leuven (BELGIUM) – December 15, 2016, 3:00h CET – TiGenix NV (Euronext Brussels: TIG; “TiGenix”), an advanced biopharmaceutical company focused on developing and... Read More →
TiGenix haalt $35,65 miljoen op met beursintroductie NASDAQ
/
Date15 Dec 2016
PERSBERICHTGEREGLEMENTEERDE INFORMATIE Leuven (BELGIE) – 15 december 2016, 3:00u CET – TiGenix NV (Euronext Brussel: TIG; “TiGenix”), een geavanceerd biofarmaceutisch bedrijf gespecialiseerd in de ontwikkeling... Read More →
DEINOVE validates key milestone 3 of its Deinochem program and receives €0.8 million from ADEME
/
Date14 Dec 2016
PR in English.pdf ADEME has validated key step 3 of the DEINOCHEM program after the performance targets were met for the production of the compounds... Read More →
Deinove valide l'étape-clé 3 de son programme Deinochem et reçoit 0,8m€ de l'ADEME
/
Date14 Dec 2016
CP en français.pdf L’ADEME a validé l’étape-clé 3 du programme DEINOCHEM suite à l’atteinte de niveaux de performance cibles dans la production des composés visés.... Read More →
CareSource Reminds Kentuckians of Upcoming Deadlines
/
Date14 Dec 2016
DAYTON, Ohio, Dec. 14, 2016 (GLOBE NEWSWIRE) — CareSource reminds consumers to enroll in Marketplace coverage before the December 15 deadline to avoid a gap... Read More →
300 Chefs to Bike 300 Miles and Raise Funds for 20 Million Meals for Hungry Kids
/
Date14 Dec 2016
Washington, D.C., Dec. 14, 2016 (GLOBE NEWSWIRE) — This coming May, 300 notable chefs and food industry professionals will swap their aprons for spandex and... Read More →
Syndax Pharmaceuticals Announces Collaboration with the National Cancer Institute to Develop Entinostat and SNDX-6352 for the Treatment of Cancer
/
Date14 Dec 2016
WALTHAM, Mass., Dec. 14, 2016 (GLOBE NEWSWIRE) — Syndax Pharmaceuticals, Inc. (“Syndax,” or “we”) (Nasdaq:SNDX), a clinical stage biopharmaceutical company focused on developing entinostat and... Read More →
KemPharm’s KP415, An Investigational Prodrug of D-Methylphenidate, Completes Phase 1 Proof-of-Concept Trial for the Treatment of ADHD
/
Date14 Dec 2016
KemPharm’s KP415, An Investigational Prodrug of D-Methylphenidate, Completes Phase 1 Proof-of-Concept Trial for the Treatment of ADHD Both Early and Extended Release of the Methylphenidate... Read More →